电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

HFE 抗体 (C-Term)

This 兔 多克隆 anti-HFE antibody specifically detects HFE in WB 和 ELISA. The antibody is reactive with 大鼠 samples.
产品编号 ABIN3172609
发货至: 中国
Contact our Customer Service for availability and price in your country. Contact Info

Our Local Distributor

中国
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
4A Biotech Co.,Ltd.
Tel +86 (0512) 65829739 传真 +86 (010) 6788 5057

Quick Overview for HFE 抗体 (C-Term) (ABIN3172609)

抗原

See all HFE 抗体
HFE (Hemochromatosis (HFE))

适用

  • 53
  • 8
  • 7
  • 5
  • 5
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
大鼠

宿主

  • 48
  • 6

克隆类型

  • 49
  • 5
多克隆

标记

  • 26
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This HFE antibody is un-conjugated

应用范围

  • 42
  • 20
  • 14
  • 13
  • 13
  • 5
  • 5
  • 5
  • 3
  • 3
  • 1
  • 1
Western Blotting (WB), ELISA
  • 抗原表位

    • 16
    • 5
    • 4
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    C-Term

    交叉反应

    大鼠

    交叉反应 (详细)

    Calculated cross reactivity: Rt

    产品特性

    HFE Protein (HLA-H)

    纯化方法

    Purified by immunoaffinity chromatography.

    免疫原

    An 18-aa peptide sequence within the C-terminus of rat HFE (1) was synthesized, coupled to KLH

    亚型

    IgG
  • 应用备注

    Optimal working conditions should be determined by the investigator.

    限制

    仅限研究用
  • 状态

    Liquid

    缓冲液

    Supplied as a liquid in PBS, pH 7.4 and 0.09 % sodium azide, 40 % glycerol.

    储存液

    Sodium azide

    注意事项

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    储存条件

    -20 °C

    储存方法

    -20°C
  • 抗原

    HFE (Hemochromatosis (HFE))

    别名

    HFE Protein

    途径

    Transition Metal Ion Homeostasis, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
You are here: